EUVIMEDEUVIMED entdecken
Crossref

Accelerated approvals: Early-phase success or premature authorization?

Xiangyun Mao, G Caleb Alexander, Guanqiao Li

Cancer Cell · 2024-11 · 42 (11) · 1799-1802

DOI: 10.1016/j.ccell.2024.09.005 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Cell, 2024-11. Verfasst von Xiangyun Mao und 2 weiteren Autor:innen. Beteiligte Einrichtung: Vanke School of Public Health, Tsinghua University, Beijing, China; Institute for Healthy China, Tsinghua University, Beijing, China. Hauptthemen laut MEDLINE: Drug Approval, United States Food and Drug Administration, Clinical Trials as Topic. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 15 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Beijing Nova Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drug ApprovalUnited States Food and Drug AdministrationClinical Trials as TopicHumansUnited States

Autor:innen und Institutionen

  • Vanke School of Public Health, Tsinghua University, Beijing, China; Institute for Healthy China, Tsinghua University, Beijing, China.
  • Division of General Internal Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA; Center for Drug Safety and Effectiveness, Johns Hopkins Bloomberg School of Public Health, Baltimore, Marylan…
  • Vanke School of Public Health, Tsinghua University, Beijing, China; Institute for Healthy China, Tsinghua University, Beijing, China. Electronic address: guanqiaoli@tsinghua.edu.cn.

Förderung

  • National Natural Science Foundation of China
  • Beijing Nova Program

Zitieren

APA

Mao, X., Alexander, G. C., & Li, G. (2024). Accelerated approvals: Early-phase success or premature authorization?. Cancer Cell, 42(11), 1799-1802. https://doi.org/10.1016/j.ccell.2024.09.005

Vancouver

Mao X, Alexander GC, Li G. Accelerated approvals: Early-phase success or premature authorization?. Cancer Cell. 2024;42(11):1799-1802. doi:10.1016/j.ccell.2024.09.005

BibTeX
@article{Mao2024,
  author = {Mao, Xiangyun and Alexander, G Caleb and Li, Guanqiao},
  title = {Accelerated approvals: Early-phase success or premature authorization?},
  journal = {Cancer Cell},
  year = {2024},
  volume = {42},
  number = {11},
  pages = {1799--1802},
  doi = {10.1016/j.ccell.2024.09.005}
}
Kostenlos starten →